Financial Performance - The company's operating revenue for Q3 2022 was ¥2,245,567,181.07, representing a year-on-year increase of 31.55%[4] - The net profit attributable to shareholders for Q3 2022 was ¥296,445,411.87, reflecting a significant increase of 75.49% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥271,508,120.86, up 87.66% year-on-year[4] - The basic earnings per share for Q3 2022 was ¥1.0377, an increase of 74.67% compared to the same period last year[4] - Net profit for the first three quarters of 2022 reached ¥753,957,420.57, compared to ¥738,504,004.16 in the same period of 2021, reflecting an increase of about 2.5%[21] - Operating revenue for the first three quarters of 2022 was ¥5,964,238,674.51, up from ¥5,658,367,390.18, indicating a growth of approximately 5.4% year-over-year[19] - The total comprehensive income attributable to the parent company for Q3 2022 was CNY 755,045,704.07, compared to CNY 724,898,915.03 in Q3 2021, reflecting an increase of approximately 4.3%[22] Assets and Liabilities - The total assets at the end of the reporting period were ¥12,837,428,593.14, an increase of 7.58% from the end of the previous year[5] - Total assets increased to ¥12,837,428,593.14, up from ¥11,933,382,346.75, representing a growth of approximately 7.5% year-over-year[19] - Total liabilities increased to ¥4,537,600,516.48 from ¥4,074,352,613.26, showing a growth of approximately 11.4% year-over-year[19] - The total equity attributable to shareholders increased to ¥8,299,828,076.66 from ¥7,859,029,733.49, representing a growth of about 5.6%[19] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥1,364,471,739.28, showing a substantial increase of 190.84% compared to the same period last year[4] - Cash inflow from operating activities for the first three quarters of 2022 was CNY 6,902,923,517.41, up from CNY 6,000,209,794.14 in the same period of 2021, representing an increase of about 15%[24] - Net cash flow from operating activities for Q3 2022 was CNY 1,364,471,739.28, significantly higher than CNY 469,145,275.51 in Q3 2021[24] - The net increase in cash and cash equivalents for Q3 2022 was CNY 194,782,106.46, down from CNY 650,320,359.78 in Q3 2021[26] - The ending balance of cash and cash equivalents as of Q3 2022 was CNY 1,514,678,336.39, compared to CNY 2,774,629,050.32 at the end of Q3 2021[26] Financial Management - The company received government subsidies amounting to ¥12,594,734.86 during the reporting period, which are closely related to its normal business operations[6] - The company has engaged in multiple financial management strategies, including investments in money market instruments[12] - The company has a significant relationship with CITIC Bank, utilizing their structured deposit products extensively[12] - The company maintains a diversified portfolio of financial instruments to optimize returns while managing risks[12] - The company has not planned any future entrusted financial management projects as of the reporting date[12] Structured Deposits - The company has multiple structured deposits with a total amount of 1.5 billion yuan, with varying annualized return rates between 3.20% and 3.45%[12] - The total amount of structured deposits from CCB Changzhou New North Branch reached 1,000,000,000 CNY, with a recovery amount of 1,481,473 CNY for the first issuance[13] - CITIC Bank New North Branch reported a total of 400,000,000 CNY in structured deposits, with a recovery amount of 2,892,055 CNY for one of the issuances[13] - The structured deposits from CITIC Bank included a significant issuance of 200,000,000 CNY with a recovery amount of 1,430,137 CNY[13] - The structured deposits from CITIC Bank also included a 130,000,000 CNY issuance with a recovery amount of 1,104,822 CNY[13] - The total amount of structured deposits issued in the third quarter of 2022 was significant, with multiple issuances exceeding CNY 100 million each[14][15] Research and Development - Research and development expenses rose to ¥366,762,664.23, compared to ¥263,170,700.83 in the previous year, marking an increase of about 39.4%[21]
星宇股份(601799) - 2022 Q3 - 季度财报